Clinical Trial

IO Vancomycin Spine

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusion surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-19; most recent amendment 2026-03-24.
Trial Details
NCT Number NCT06748144
Lead Sponsor The Methodist Hospital Research Institute
Conditions Lumbar Fusion Surgery
Enrollment 30 participants
Start Date 2026-05
Primary Completion 2027-04 (estimated)
Study Completion 2030-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-25